Volume 11, Number 1—January 2005
Research
Multidrug-Resistant Acinetobacter baumannii
Aharon Abbo*, Shiri Navon-Venezia*, Orly Hammer-Muntz*, Tami Krichali*, Yardena Siegman-Igra*, and Yehuda Carmeli*
Table 3
Multivariate analysis for risk factors for Acinetobacter baumannii*†
| Parameter‡ | OR | 95% CI | p value |
|---|---|---|---|
| Male sex | 3.84 | 1.63–8.99 | 0.002 |
| Ischemic heart disease | 3.35 | 1.44–7.77 | 0.005 |
| Mechanical ventilation | 6.27 | 2.27–17.33 | <0.001 |
| Penicillin use§ | 0.38 | 0.16–0.90 | 0.029 |
| Metronidazole use | 2.33 | 0.98–5.83 | 0.071 |
| Any home antimicrobial drug treatment | 4.74 | 1.31–17.15 | 0.018 |
*OR, odds ratio; CI, confidence interval.
†Adjusted for length of hospital stay prior to entry to the study.
‡All parameters had been present before A. baumannii identification.
§Including semisynthetics with or without a β-lactamase inhibitor (never sulbactam).
